31: Burden of MASH in patients with Type 2 Diabetes Mellitus
Fetch error
Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on August 12, 2024 17:16 ()
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 410771746 series 3499760
Welcome to our latest episode featuring Professor Emmanouil Tsochatzis, a distinguished Professor of Hepatology and Honorary Consultant at the UCL Institute for Liver and Digestive Health in the Royal Free Hospital. Today, we embark on an exploration of the profound impact of Metabolic-Associated Steatohepatitis (MASH) on individuals grappling with type 2 diabetes mellitus. Prepare to delve into the intricate details of this pressing issue as Professor Tsochatzis sheds light on the burden of MASH, unraveling its complexities and implications for those affected. Moreover, we'll uncover his latest groundbreaking research, recently published in The Lancet, advocating for the implementation of liver health checks in people with type 2 diabetes. Join us for an enlightening discussion at the forefront of liver health and metabolic diseases, as we navigate the terrain of MASH and its intersection with diabetes. Stay tuned for insights that could redefine our approach to managing these conditions.
31 episodes